Run ID: ERR1633786
Sample name:
Date: 2024-04-15T00:13:01.515193
Number of reads: 2655830
Percentage reads mapped: 99.6
Median coverage: 47.0
Strain: lineage4.3.2.1
Spoligotype:
Drug-resistance: HR-TB
Lineage | Family | RDs | Frequency |
---|---|---|---|
lineage4.3 | Euro-American (LAM) | None | 0.99 |
lineage4.3.2 | Euro-American (LAM) | None | 1.0 |
lineage4.3.2.1 | Euro-American (LAM) | RD761 | 1.0 |
lineage4 | Euro-American | None | 1.0 |
Drug | Resistance | Supporting mutations | WHO confidence | Comment |
---|---|---|---|---|
rifampicin | ||||
isoniazid | katG | c.-17275_*26379del | Assoc w R | High-level resistance |
ethambutol | ||||
pyrazinamide | pncA | c.-1565_*43777del | Assoc w R | |
c.-16937_*23680del | Assoc w R | |||
c.-15108_*16699del | Assoc w R | |||
streptomycin | ||||
fluoroquinolones | ||||
moxifloxacin | ||||
ofloxacin | ||||
levofloxacin | ||||
ciprofloxacin | ||||
aminoglycosides | ||||
amikacin | ||||
capreomycin | tlyA | c.-38795_19del | Assoc w R | |
c.-38257_*3783del | Assoc w R | |||
c.-34795_580del | Assoc w R | |||
c.-27543_*11737del | Assoc w R | |||
c.-22335_*8005del | Assoc w R | |||
c.-15480_*16852del | Assoc w R | |||
c.-2895_*27763del | Assoc w R | |||
c.53_*8154del | Assoc w R | |||
kanamycin | ||||
cycloserine | ||||
ethionamide | ethA | c.-23641_*19056del | Assoc w R | |
c.-22383_*13719del | Assoc w R | |||
clofazimine | pepQ | c.-6286_*15454del | Assoc w R - Interim | |
c.-37166_1115del | Assoc w R - Interim | |||
para-aminosalicylic_acid | thyA | c.-9942_*13257del | Mutation from literature | |
c.-33681_*13005del | Mutation from literature | |||
c.-40277_*3111del | Mutation from literature | |||
c.-36986_*2800del | Mutation from literature | |||
delamanid | fbiD | c.-46250_*1759del | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
c.-30387_*8214del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-15606_*10263del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-2681_*38826del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
fbiA | c.-41610_*2614del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |
c.-24102_*3483del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-1417_*19417del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
ddn | c.-27772_*10671del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |
c.-14472_*14619del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-8716_*8586del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
bedaquiline | pepQ | c.-6286_*15454del | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
c.-37166_1115del | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV | ||
linezolid |
Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence | Comment |
---|---|---|---|---|---|---|---|
tlyA | 1879144 | c.-38795_19del | frameshift_variant | 0.98 | capreomycin | Assoc w R | |
tlyA | 1879682 | c.-38257_*3783del | transcript_ablation | 0.97 | capreomycin | Assoc w R | |
tlyA | 1883144 | c.-34795_580del | frameshift_variant | 0.97 | capreomycin | Assoc w R | |
tlyA | 1890396 | c.-27543_*11737del | transcript_ablation | 0.94 | capreomycin | Assoc w R | |
tlyA | 1895604 | c.-22335_*8005del | transcript_ablation | 0.98 | capreomycin | Assoc w R | |
tlyA | 1902459 | c.-15480_*16852del | transcript_ablation | 0.95 | capreomycin | Assoc w R | |
tlyA | 1915044 | c.-2895_*27763del | transcript_ablation | 0.94 | capreomycin | Assoc w R | |
tlyA | 1917991 | c.53_*8154del | frameshift_variant&stop_lost&splice_region_variant | 0.96 | capreomycin | Assoc w R | |
katG | 2127509 | c.-17275_*26379del | transcript_ablation | 0.9 | isoniazid | Assoc w R | High-level resistance |
pncA | 2244903 | c.-1565_*43777del | transcript_ablation | 0.95 | pyrazinamide | Assoc w R | |
pncA | 2265000 | c.-16937_*23680del | transcript_ablation | 0.93 | pyrazinamide | Assoc w R | |
pncA | 2271981 | c.-15108_*16699del | transcript_ablation | 0.94 | pyrazinamide | Assoc w R | |
pepQ | 2843845 | c.-6286_*15454del | transcript_ablation | 0.93 | bedaquiline | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
clofazimine | Assoc w R - Interim | ||||||
pepQ | 2859303 | c.-37166_1115del | frameshift_variant | 0.96 | bedaquiline | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
clofazimine | Assoc w R - Interim | ||||||
thyA | 3060422 | c.-9942_*13257del | transcript_ablation | 0.94 | para-aminosalicylic_acid | Mutation from literature | |
thyA | 3060674 | c.-33681_*13005del | transcript_ablation | 0.93 | para-aminosalicylic_acid | Mutation from literature | |
thyA | 3070568 | c.-40277_*3111del | transcript_ablation | 0.96 | para-aminosalicylic_acid | Mutation from literature | |
thyA | 3070879 | c.-36986_*2800del | transcript_ablation | 0.93 | para-aminosalicylic_acid | Mutation from literature | |
fbiD | 3292867 | c.-46250_*1759del | transcript_ablation | 0.98 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiD | 3308730 | c.-30387_*8214del | transcript_ablation | 0.93 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiD | 3323511 | c.-15606_*10263del | transcript_ablation | 0.96 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiD | 3336436 | c.-2681_*38826del | transcript_ablation | 0.96 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiA | 3598932 | c.-41610_*2614del | transcript_ablation | 0.97 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiA | 3616440 | c.-24102_*3483del | transcript_ablation | 0.96 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiA | 3639125 | c.-1417_*19417del | transcript_ablation | 0.97 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3959071 | c.-27772_*10671del | transcript_ablation | 0.96 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3972371 | c.-14472_*14619del | transcript_ablation | 0.94 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3978127 | c.-8716_*8586del | transcript_ablation | 0.96 | pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ethA | 4306947 | c.-23641_*19056del | transcript_ablation | 0.97 | ethionamide | Assoc w R | |
ethA | 4312284 | c.-22383_*13719del | transcript_ablation | 0.97 | ethionamide | Assoc w R |
Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence |
---|---|---|---|---|---|---|
gyrB | 5520 | p.Pro94Leu | missense_variant | 1.0 | levofloxacin | Not assoc w R |
moxifloxacin | Not assoc w R | |||||
gyrB | 7222 | c.1983C>T | synonymous_variant | 1.0 | levofloxacin | Not assoc w R |
moxifloxacin | Not assoc w R | |||||
gyrA | 7362 | p.Glu21Gln | missense_variant | 1.0 | levofloxacin | Not assoc w R |
moxifloxacin | Not assoc w R | |||||
gyrA | 7585 | p.Ser95Thr | missense_variant | 1.0 | levofloxacin | Not assoc w R |
moxifloxacin | Not assoc w R | |||||
gyrA | 9304 | p.Gly668Asp | missense_variant | 1.0 | levofloxacin | Not assoc w R |
moxifloxacin | Not assoc w R | |||||
rpoC | 764995 | c.1626C>G | synonymous_variant | 1.0 | rifampicin | Not assoc w R |
mmpL5 | 775639 | p.Ile948Val | missense_variant | 1.0 | clofazimine | Not assoc w R |
bedaquiline | Not assoc w R - Interim | |||||
rpsL | 781395 | c.-165T>C | upstream_gene_variant | 1.0 | streptomycin | Not assoc w R |
Rv1129c | 1237362 | c.-17610_*15711del | transcript_ablation | 0.92 | moxifloxacin | Uncertain significance |
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
Rv1129c | 1248101 | c.-7759_*4972del | transcript_ablation | 0.97 | moxifloxacin | Uncertain significance |
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
rrs | 1471659 | n.-187C>T | upstream_gene_variant | 0.98 | streptomycin | |
kanamycin | ||||||
capreomycin | ||||||
amikacin | ||||||
rrs | 1472337 | n.492C>T | non_coding_transcript_exon_variant | 1.0 | streptomycin | Not assoc w R - Interim |
kanamycin | Not assoc w R | |||||
capreomycin | Not assoc w R | |||||
amikacin | Not assoc w R | |||||
rpsA | 1829630 | c.-3911_*43280del | transcript_ablation | 0.98 | pyrazinamide | Uncertain significance |
rpsA | 1830817 | c.-2724_*5716del | transcript_ablation | 0.98 | pyrazinamide | Uncertain significance |
tsnR | 1836520 | c.-17085_*30474del | transcript_ablation | 0.96 | linezolid | Uncertain significance |
tsnR | 1836636 | c.-16969_*23365del | transcript_ablation | 0.98 | linezolid | Uncertain significance |
tsnR | 1836955 | c.-16650_*2884del | transcript_ablation | 0.96 | linezolid | Uncertain significance |
tsnR | 1848115 | c.-5490_*27854del | transcript_ablation | 0.97 | linezolid | Uncertain significance |
tsnR | 1854300 | p.Leu232Pro | missense_variant | 1.0 | linezolid | Not assoc w R |
tlyA | 1917972 | c.33A>G | synonymous_variant | 1.0 | capreomycin | Not assoc w R |
bacA | 2035506 | c.-15190_*27302del | transcript_ablation | 0.95 | streptomycin | Uncertain significance |
kanamycin | Uncertain significance | |||||
capreomycin | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
bacA | 2045705 | c.-23803_*17103del | transcript_ablation | 0.94 | streptomycin | Uncertain significance |
kanamycin | Uncertain significance | |||||
capreomycin | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
bacA | 2047182 | c.-16884_*15626del | transcript_ablation | 0.93 | streptomycin | Uncertain significance |
kanamycin | Uncertain significance | |||||
capreomycin | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
PPE35 | 2164722 | c.1126_*2926del | stop_lost&conservative_inframe_deletion&splice_region_variant | 0.97 | pyrazinamide | |
Rv1979c | 2201342 | c.-3517_*20376del | transcript_ablation | 0.94 | clofazimine | Uncertain significance |
bedaquiline | Uncertain significance | |||||
Rv1979c | 2223293 | c.-129A>G | upstream_gene_variant | 1.0 | clofazimine | Not assoc w R |
bedaquiline | Not assoc w R - Interim | |||||
pncA | 2290107 | c.-866T>A | upstream_gene_variant | 1.0 | pyrazinamide | |
kasA | 2492957 | c.-25157_*8426del | transcript_ablation | 0.94 | isoniazid | |
eis | 2696062 | c.-12769_*18061del | transcript_ablation | 0.92 | amikacin | Uncertain significance |
kanamycin | Uncertain significance | |||||
eis | 2710830 | c.-8544_*3293del | transcript_ablation | 0.97 | amikacin | Uncertain significance |
kanamycin | Uncertain significance | |||||
Rv2477c | 2757375 | c.-18464_*24990del | transcript_ablation | 0.93 | ethambutol | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
levofloxacin | Uncertain significance | |||||
kanamycin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
ribD | 2951935 | c.-34903_*8437del | transcript_ablation | 0.95 | para-aminosalicylic_acid | |
ribD | 2961956 | c.-24882_*5799del | transcript_ablation | 0.95 | para-aminosalicylic_acid | |
Rv2680 | 2965850 | c.-30254_*605del | transcript_ablation | 0.95 | capreomycin | Uncertain significance |
Rv2680 | 2984241 | c.-11863_*1503del | transcript_ablation | 0.96 | capreomycin | Uncertain significance |
Rv2680 | 2989311 | c.-6793_*3955del | transcript_ablation | 0.96 | capreomycin | Uncertain significance |
thyA | 3073868 | p.Thr202Ala | missense_variant | 1.0 | para-aminosalicylic_acid | |
ald | 3083765 | c.-3054_*25732del | transcript_ablation | 0.96 | cycloserine | |
ald | 3085718 | c.-1101_*8107del | transcript_ablation | 0.93 | cycloserine | |
ald | 3086788 | c.-32T>C | upstream_gene_variant | 1.0 | cycloserine | |
Rv3083 | 3420595 | c.-27908_*8780del | transcript_ablation | 0.95 | ethionamide | Uncertain significance |
Rv3083 | 3434746 | c.-13757_*28950del | transcript_ablation | 0.93 | ethionamide | Uncertain significance |
Rv3083 | 3449275 | c.773_*7292del | frameshift_variant&stop_lost&splice_region_variant | 0.96 | ethionamide | Uncertain significance |
Rv3083 | 3449736 | c.1234_*38453del | stop_lost&conservative_inframe_deletion&splice_region_variant | 0.95 | ethionamide | |
whiB7 | 3547050 | c.-17131_*21350del | transcript_ablation | 0.97 | streptomycin | Uncertain significance |
amikacin | Uncertain significance | |||||
kanamycin | Uncertain significance | |||||
whiB7 | 3565901 | c.-20858_*2499del | transcript_ablation | 0.95 | streptomycin | Uncertain significance |
amikacin | Uncertain significance | |||||
kanamycin | Uncertain significance | |||||
Rv3236c | 3586579 | c.-18620_*25379del | transcript_ablation | 0.95 | pyrazinamide | Uncertain significance |
Rv3236c | 3594447 | c.-22996_*17511del | transcript_ablation | 0.95 | pyrazinamide | Uncertain significance |
Rv3236c | 3598517 | c.-10309_*13441del | transcript_ablation | 0.95 | pyrazinamide | Uncertain significance |
Rv3236c | 3598621 | c.-17284_*13337del | transcript_ablation | 0.96 | pyrazinamide | Uncertain significance |
Rv3236c | 3601012 | c.-11987_*10946del | transcript_ablation | 0.96 | pyrazinamide | Uncertain significance |
Rv3236c | 3607818 | c.50_*4140del | frameshift_variant&stop_lost&splice_region_variant | 0.97 | pyrazinamide | Uncertain significance |
mtrB | 3625065 | p.Met517Leu | missense_variant | 1.0 | bedaquiline | Uncertain significance |
rifampicin | Not assoc w R | |||||
alr | 3816428 | c.-5145_*23765del | transcript_ablation | 0.96 | cycloserine | |
alr | 3838224 | c.-11802_*1969del | transcript_ablation | 0.96 | cycloserine | |
rpoA | 3848185 | c.-16826_*29278del | transcript_ablation | 0.96 | rifampicin | |
rpoA | 3868362 | c.-38781_*9101del | transcript_ablation | 0.98 | rifampicin | |
rpoA | 3873538 | c.-43756_*3925del | transcript_ablation | 0.98 | rifampicin | |
clpC1 | 4014460 | c.-681_*23697del | transcript_ablation | 0.95 | pyrazinamide | |
panD | 4017822 | c.-21679_*26039del | transcript_ablation | 0.94 | pyrazinamide | Uncertain significance |
panD | 4026791 | c.-25199_*17070del | transcript_ablation | 0.95 | pyrazinamide | Uncertain significance |
panD | 4034108 | c.-11110_*9753del | transcript_ablation | 0.95 | pyrazinamide | Uncertain significance |
clpC1 | 4038287 | c.2418C>T | synonymous_variant | 1.0 | pyrazinamide | Not assoc w R |
glpK | 4102251 | c.-7482_*35950del | transcript_ablation | 0.97 | ethambutol | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
glpK | 4102779 | c.942_*35422del | frameshift_variant&stop_lost&splice_region_variant | 0.96 | ethambutol | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
glpK | 4103269 | c.-1920_*34932del | transcript_ablation | 0.96 | ethambutol | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
glpK | 4113112 | c.-9885_*25089del | transcript_ablation | 0.97 | ethambutol | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
glpK | 4113972 | c.326_*24229del | frameshift_variant&stop_lost&splice_region_variant | 0.98 | ethambutol | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
levofloxacin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
embA | 4229854 | c.-13378_*453del | transcript_ablation | 0.95 | ethambutol | Uncertain significance |
embA | 4234112 | c.-9120_*27554del | transcript_ablation | 0.97 | ethambutol | Uncertain significance |
embA | 4240504 | c.-2728_*21302del | transcript_ablation | 0.98 | ethambutol | Uncertain significance |
embC | 4242643 | c.2781C>T | synonymous_variant | 1.0 | ethambutol | Not assoc w R |
aftB | 4268296 | c.-24979_540del | start_lost&conservative_inframe_deletion | 0.96 | ethambutol | Uncertain significance |
whiB6 | 4338145 | c.-29795_*25del | transcript_ablation | 0.97 | capreomycin | Uncertain significance |
amikacin | Uncertain significance | |||||
kanamycin | Uncertain significance | |||||
whiB6 | 4338595 | c.-75delG | upstream_gene_variant | 1.0 | capreomycin | Not assoc w R |
amikacin | Not assoc w R | |||||
kanamycin | Not assoc w R | |||||
whiB6 | 4338732 | c.-211C>T | upstream_gene_variant | 1.0 | capreomycin | |
amikacin | ||||||
kanamycin | ||||||
gid | 4408156 | p.Leu16Arg | missense_variant | 1.0 | streptomycin | Not assoc w R |